Natural Products and Drug Discovery
MDPI, Apr 22, 2020 - Medical - 392 pages
Natural products hold a prominent position in the current discovery and development of drugs and have diverse indications for both human and animal health. Plants, in particular, play a leading role as a source of specialized metabolites with medical effects. Other organisms, such as marine and terrestrial animals and microorganisms, produce very important drug candidate molecules. Specialized metabolites from these varied natural sources can be used directly as bioactive compounds or drug precursors. In addition, due to their broad chemical diversity, they can act as drug prototypes and/or be used as pharmacological tools for different targets. Some examples of natural metabolites that have been developed into useful medical drug are cardiotonic digoxin from Digitalis sp., antimalarial artemisinin from Artemisia annua, anti-cancer taxol from Taxus sp., or podophyllotoxin from Podophyllum peltatum, which served as a synthetic model for the anti-cancer etoposide. The study of natural products is still attracting great scientific attention and their current importance, as a valuable lead for drug discovery, is undebatable. I cordially invite authors to contribute original articles, as well as survey articles, that give the readers of Molecules **MOLECULES NEEDS TO BE ITALICIZED** updated and new perspectives on natural products in drug discovery, including but not limited to natural sources, identification and separation of bioactive phytochemicals, standardization, new biological targets, pre-clinical and clinical trials, pharmacological effects/side effects, and bioassays.
What people are saying - Write a review
We haven't found any reviews in the usual places.
acid activity added addition administration analysis animals antimicrobial antioxidant artemisinin assay authors behavior bioactive brain Ca2+ cancer carotenoids celastrol cells cerebellum characterized Chem chemical chromatography clover compared compounds concentration CrossRef derivatives described detected determined diabetic disease DMSO drug early effects enzyme evaluated expression extract Figure flavonoids followed Food fraction fragmentation function further genes glucose GLUT4 glycosides HPLC human identified increased indicated induced inhibition inhibitory isolated Italy ketamine levels lines mass mechanism medicinal metabolites method mice molecular Molecules natural observed obtained Orobanche oxidative stress pain patens pathway peptides performed phenolic plant positive potential prevent previously protein PubMed reported Research resistance respectively role saline samples sativa showed signaling solution species spectrum structure Table treatment University values Wang